267 related articles for article (PubMed ID: 7683179)
1. Hepatitis C virus infection in chronic liver disease in Somalia.
Aceti A; Taliani G; Bruni R; Sharif OS; Moallin KA; Celestino D; Quaranta G; Sebastiani A
Am J Trop Med Hyg; 1993 Apr; 48(4):581-4. PubMed ID: 7683179
[TBL] [Abstract][Full Text] [Related]
2. Low risk of sexual transmission of hepatitis C virus in Somalia.
Watts DM; Corwin AL; Omar MA; Hyams KC
Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
[TBL] [Abstract][Full Text] [Related]
4. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
[TBL] [Abstract][Full Text] [Related]
5. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.
Bile K; Aden C; Norder H; Magnius L; Lindberg G; Nilsson L
Scand J Infect Dis; 1993; 25(5):559-64. PubMed ID: 7506842
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Oshita M; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1993 Feb; 17(2):170-4. PubMed ID: 8383157
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
8. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
9. Recombinant immunoblot assays for hepatitis C in human immunodeficiency virus type 1-infected US Navy personnel.
Bryan JP; Sjogren MH; Malone JL; MacArthy P; Kao TC; Wagner K; Sheffield J; Smith E; Perine PL
J Infect Dis; 1993 Mar; 167(3):715-9. PubMed ID: 8382719
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period.
Verbaan H; Widell A; Lindgren S; Lindmark B; Nordenfelt E; Eriksson S
J Intern Med; 1992 Jul; 232(1):33-42. PubMed ID: 1322443
[TBL] [Abstract][Full Text] [Related]
13. Is autoimmune chronic active hepatitis a HCV-related disease?
Magrin S; Craxì A; Fiorentino G; Fabiano C; Provenzano G; Pinzello GB; Palazzo U; Almasio P; Pagliaro L
J Hepatol; 1991 Jul; 13(1):56-60. PubMed ID: 1717543
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of anti-hepatitis C virus antibody in healthy blood donors in China: enzyme immunoassay and recombinant immunoblot].
Zhang YY; Yan XB; Li FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):695-8, 730-1. PubMed ID: 1667749
[TBL] [Abstract][Full Text] [Related]
15. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis.
Nishiguchi S; Kuroki T; Ueda T; Fukuda K; Takeda T; Nakajima S; Shiomi S; Kobayashi K; Otani S; Hayashi N
Ann Intern Med; 1992 Jan; 116(1):21-5. PubMed ID: 1309200
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibody to hepatitis C virus in HBsAg-negative chronic liver disease in Hong Kong using different assays.
Lai JY; Tam JS; Lam LY; Leung NW
J Med Virol; 1992 Jun; 37(2):158-60. PubMed ID: 1321225
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.
Tsai JF; Chang WY; Jeng JE; Ho MS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Tsai JH
J Med Virol; 1993 Dec; 41(4):296-300. PubMed ID: 7508973
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
Chen DS; Kuo GC; Sung JL; Lai MY; Sheu JC; Chen PJ; Yang PM; Hsu HM; Chang MH; Chen CJ
J Infect Dis; 1990 Oct; 162(4):817-22. PubMed ID: 2169497
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
20. Reliability of immunoassays for anti-HCV antibodies (ELISA and RIBA II) in patients with essential mixed cryoglobulinemia (EMC).
Monteverde A; Airoldi G; Ballarè M; Fortina G; Quaglia V; Pigatto A; Manzini P
Clin Exp Rheumatol; 1993; 11(6):609-13. PubMed ID: 7507807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
